Posted in

General Surgery

Researchers leverage AI to identify sepsis within 12 hours

In a medical field like critical care, where time can mean life or death, a sepsis diagnosis is like the final buzzer. Each year, according to the Centers for Disease Control and Prevention, at least 1.7 million adults in the U.S. develop the condition. Sepsis, the body’s exaggerated response to…

A life-saving attitude

In 1987, a doctor informed second-grade teacher Laurie Waldo that she had bone cancer. In 2006, she was told she had a malignant tumor in her right breast. In 2019, Waldo learned she had a chest wall recurrence of breast cancer following her mastectomy. That same year, she was told…

Pancreatic cancer trials fail to include minorities despite worse outcomes

Kelly Herremans, M.D. Despite the fact that certain racial and ethnic minorities get pancreatic cancer more often, are diagnosed at a younger age and die sooner, clinical trials fail to include representative proportions of non-White patients at every phase of study, according to research that was selected for…

Drs. Moldawer, Efron and team receive RM1 award for dysfunctional myelopoiesis

Lyle Moldawer, Ph.D., Philip A. Efron, M.D., and multidisciplinary collaborators Michael Kladde, Ph.D., and Laurence Morel, Ph.D., have received an RM1 award to study dysfunctional myelopoiesis and myeloid-derived suppressor cells in the pathobiology of sepsis. The funding will stretch over a period of five years with an annual total award…

Black and Latinx surgeons continue to hit glass ceiling in America

Richmond, Va. — Among the upper echelons of academic surgery, Black and Latinx representation has remained flat over the past six years, according to a study published today in JAMA Surgery by researchers at Virginia Commonwealth University Massey Cancer Center and University of Florida Health. The study…